SONVF (Sonova Holding AG) ROCE %: 18.83% (As of Mar. 2026)


SONVF Sonova Holding AG SONVF
89 GF Score
Price $243.88
GF Value $314.08
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Sonova Holding AG ROCE %?

Sonova Holding AG SONVF -0.49% 89 ROCE % is 18.83% as of Mar. 2026. GuruFocus rates SONVF with a GF Score™ of 89/100 and a GF Value™ of $314.08 (Modestly Undervalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sonova Holding AG's annualized ROCE % for the quarter that ended in Mar. 2026 was 18.83%.

Sonova Holding AG  (OTCPK:SONVF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sonova Holding AG ROCE % Related Terms

Sonova Holding AG ROCE % Historical Data

* Premium members only.

The historical data trend for Sonova Holding AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonova Holding AG ROCE % Chart

Sonova Holding AG Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.13 17.36 15.14 15.71 16.00

Sonova Holding AG Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.15 13.16 19.17 13.10 18.83
SONVF
89GF Score
Sonova Holding AG SONVF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sonova Holding AG ROCE % Calculation

Sonova Holding AG's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=851.518/( ( (6704.617 - 1697.714) + (7149.498 - 1509.59) )/ 2 )
=851.518/( (5006.903+5639.908)/ 2 )
=851.518/5323.4055
=16.00 %

Sonova Holding AG's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=1024.514/( ( (6918.729 - 1677.553) + (7149.498 - 1509.59) )/ 2 )
=1024.514/( ( 5241.176 + 5639.908 )/ 2 )
=1024.514/5440.542
=18.83 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 18.83% mean?
Sonova Holding AG (SONVF) has a ROCE % of 18.83% as of Mar. 2026.
Is Sonova Holding AG's ROCE % too high?
Sonova Holding AG's current ROCE % is 18.83%. The Medical Devices & Instruments industry median ROCE % is 2.23. Sonova Holding AG's value of 18.83% is 744.4% above this industry median. Overall, Sonova Holding AG has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonova Holding AG's ROCE % compare to ABT and SYK?
Sonova Holding AG's ROCE % of 18.83% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Sonova Holding AG's value of 18.83% is 744.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sonova Holding AG's current ROCE % of 18.83% is 744.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sonova Holding AG's current ROCE % is 18.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonova Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Sonova Holding AG (SONVF) is currently considered Modestly Undervalued. The stock's GF Value™ is $314.08, compared to a current price of $243.88 — trading 22.4% below its estimated fair value. The current ROCE % is 18.83% and 744.4% above the Medical Devices & Instruments industry median of 2.23. Sonova Holding AG's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Sonova Holding AG (SONVF), the current ROCE % is 18.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sonova Holding AG (SONVF) Overvalued in 2026?

Based on GuruFocus' analysis, Sonova Holding AG stock appears to be undervalued. The current stock price of $243.88 is trading 22.4% below its estimated GF Value™ of $314.08. GuruFocus considers Sonova Holding AG to be Modestly Undervalued.

Key valuation signals for SONVF:

  • ROCE %: 18.83%
  • GF Value™: $314.08 vs. price of $243.88 (22.4% below fair value)
  • GF Score™: 89/100 with 3 warning signs
  • Industry Position: 744.4% above the Medical Devices & Instruments median

No single metric tells the full story. See the SONVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sonova Holding AG Business Description

Address Laubisrutistrasse 28, Stafa, CHE, CH-8712
Sonova is one of the world's largest manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants and audio technologies.
89GF Score

Get the complete analysis for SONVF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$243.88
Price
$314.08
GF Value